enVVeno Medical Corporation(NVNO)
Health Care Equipment
Cardiovascular Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Duhay Francis Director | Sale | -140 | -0.11%130,343 | $10.30 | $1,443 | View SEC filing | |
| 2026-03-13 | Duhay Francis Director | Sale | -140 | -0.11%130,483 | $11.52 | $1,613 | View SEC filing | |
| 2025-12-12 | Duhay Francis Director | Sale | -4,900 | -3.62%130,623 | $0.36 | $1,742 | View SEC filing | |
| 2025-09-17 | Duhay Francis Director | Sale | -4,900 | -3.49%135,523 | $0.83 | $4,067 | View SEC filing | |
| 2025-01-03 | Duhay Francis Director | Purchase | +81,433 | +138.05%140,423 | $3.07 | $249,999 | View SEC filing | |
| 2025-01-02 | Gray Robert Director | Purchase | +3,500 | +7.79%48,434 | $2.94 | $10,290 | View SEC filing | |
| 2024-12-26 | Shrivastava Sanjay Director | Purchase | +5,400 | +12.87%47,367 | $2.90 | $15,660 | View SEC filing | |
| 2024-12-23 | Jenusaitis Matthew Director | Purchase | +9,620 | +21.76%53,824 | $2.53 | $24,339 | View SEC filing | |
| 2024-12-19 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +12,000 | +0.88%1,375,448 | $2.55 | $30,600 | View SEC filing | |
| 2024-03-15 | Alavi Hamed Chief Technology Officer | Sale | -8,334 | -100.00%0 | $6.22 | $51,837 | View SEC filing | |
| 2022-08-18 | Duhay Francis Director | Purchase | +7,751 | +58.90%20,911 | $6.14 | $47,591 | View SEC filing | |
| 2022-07-01 | Shrivastava Sanjay Director | Purchase | +1,000 | +34.63%3,888 | $3.85 | $3,850 | View SEC filing | |
| 2022-06-28 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +2,500 | +1.20%210,236 | $3.80 | $9,500 | View SEC filing | |
| 2021-11-19 | BERMAN ROBERT ANDREW CEO | Purchase | +2,000 | +34.87%7,736 | $7.43 | $14,860 | View SEC filing | |
| 2021-11-18 | BERMAN ROBERT ANDREW CEO | Purchase | +2,000 | +53.53%5,736 | $7.87 | $15,740 | View SEC filing | |
| 2021-08-27 | Jenusaitis Matthew Director | Purchase | +1,300 | +36.70%4,842 | $7.70 | $10,010 | View SEC filing | |
| 2021-06-21 | Gray Robert Director | Purchase | +2,000 | +55.99%5,572 | $6.25 | $12,500 | View SEC filing | |
| 2021-05-25 | Glickman Marc H. SVP & Chief Medical Officer | Purchase | +1,600 | +100.00%1,600 | $5.90 | $9,440 | View SEC filing | |
| 2021-05-19 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +3,000 | +407.61%3,736 | $5.47 | $16,410 | View SEC filing | |
| 2021-05-19 | Duhay Francis Director | Purchase | +9,492 | +258.78%13,160 | $5.33 | $50,592 | View SEC filing | |
| 2020-10-01 | Biodyne Holding, S.A. Other | Sale | -1,950,000 | -58.11%1,405,433 | $0.40 | $787,036 | View SEC filing | |
| 2020-06-08 | Biodyne Holding, S.A. 10% Owner | Sale | -225,583 | -6.30%3,355,433 | $0.33 | $74,331 | View SEC filing | |
| 2020-05-14 | Biodyne Holding, S.A. 10% Owner | Sale | -684,813 | -16.05%3,581,016 | $0.67 | $458,825 | View SEC filing | |
| 2019-04-17 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +18,382 | +100.00%18,382 | $1.36 | $25,000 | View SEC filing | |
| 2019-03-14 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +21,740 | +100.00%21,740 | $1.15 | $25,001 | View SEC filing |
1-25 of 25